There is a tendency to focus purely on the negative effects of a system that seems to be failing it's purpose. It's important to understand the system as a whole, and it's history. Has the patent system ever functioned for the purpose it was designed for? If it isn't functioning correctly now, is that in part or in whole? Is it not functioning because it has been changed, because the world has changed, or both.
Finally, is there a way to alter the system, whether that be to curtail it, expand it, or just change how it operates, that might yield a better functioning system?
Personally, I'm not for abolishing patents. They had a very clearly defined purpose (innovation encouragement) when they were first created. I think they've been mostly perverted into another purpose (wealth protection), more-so in some industries than others. They've been expanded from court rulings to cover things which were not originally thought patentable. What we need here is a well reasoned legislative overhaul. What we'll get if we're extremely lucky is a hole-ridden clusterfuck of revisions, but if we're lucky, it will somewhat address the current problems. The new problems will be something we discover and address tomorrow.
I believe the cost and delay of patent litigation is the real problem. It's important to identify the critical issue before effective change can happen.
Protections of inventions (as loose as the term "invention" might be) isn't the only avenue to innovation, but it is an avenue.
There is always going to be a pull between free/open and paid/private. It's a good thing that multiple avenues exist, because some public-good innovations may happen under one regime but not the other.
Also, I take issue with the terms of the "it should be free" conversation here. The patent isn't for the gene: the company does not hold the rights to your DNA. The patent is for the discovery of it's link to cancer.
In this exact circumstance, I question how long it would take for this gene to be identified as a causal-link to breast cancer if there was not the bait of a financial windfall. Is there a smoking gun that shows this company beat out a public institution to this discovery?
Drug research, perhaps, though we might be able to find other solutions there, or produce a much more limited form of patent for that industry alone. What else currently depends fundamentally on patents for its business model?
Looking at the many groups working on FOSS media codecs past and present (VP8, VP9, AoM, Opus, Vorbis), I'd say the media situation would actually get better in the absence of patents.
There will be little or no impact on innovation by this patent change.
Pervasive Internet and the move to putting logic on the server definitely outmodes many uses for patents, though. Take Siri. SRI invented the technology, spun off a company with the IP, which was purchased by Apple. I don't think that transaction would've happened without patent protection. But today you have an alternative model. Instead of licensing voice recognition technology for integration into products, you can provide the algorithm as a service. Now, the source code stays safely on the server side where nobody can decompile it to figure out how it works.
Humor me. When Gmail first came out, it was revolutionary. Now, you could host your own clone for $10-20/month using containerized Elastic Search indexing all of your email, with a small virtual machine ingesting your email from the internet, and providing it to you over JSON to your local mail client or through a web interface.
Voice recognition could follow the same trajectory. Computing power will increase, storage costs will continue to plummet (I've mentioned this multiple times on HN, but Samsung is predicting 128TB SSD drives in 3 years).
You don't need patents anymore, as you mentioned, because you can provide the service, not the underlying source code. But you still need to monetize quickly (if that's your goal), because the rising tide of technology can quickly supplant your lead with other competitors or open source options.
No, Boeing and the other ULA members (both as ULA and separately) are SpaceX competitors for (particularly) government contract work, what you call "congressional district graft" is part of the game they play to maximize the value and duration of those contracts (to make them politically hard to curtail), but aren't what they exist to support -- you've got what is being served and what is serving reversed.
Now, in order to profit, it has to differentiate itself from incumbents somehow, and the opportunity it is built around to do that is regarding efficiencies that allow it to offer launch services at lower costs. But, it is competing directly with ULA for business, as a simple matter of concrete fact.
There is a huge difference between protection from copying, and protection from building similar things that achieve the same goal. Patents are not simply "protection from copying".
Drug patents often cover things like "using the same body mechanism to achieve a desired result".
(Now, you can argue this is necessary to protect them, but let's be clear - it's not straight copying if i make a pill with a completely different chemical composition that ends up triggering the same mechanisms. However, it likely runs afoul of their carefully drafted patents.
I'm also aware there are chemical compound patents that would not cover me doing this, but usually, when the drug companies can, they get both)
"Intel spends billions a year on semiconductor R&D, and protects it with trade secrets"
and design mask protection (see https://en.wikipedia.org/wiki/Integrated_circuit_layout_desi...)
"Pharma companies spend billions on drug R&D and protect them with patents. "
They are also heavily subsidized, unlike your intel example. Tax payers, for example, pay about 50% of pharma's R&D costs (and pharma includes a lot more than actual R&D in R&D cost). http://www.healthnewsreview.org/2012/02/the-costly-myths-abo...
and http://www.thefiscaltimes.com/Columns/2012/02/16/What-Those-...
"Hard R&D that isn't protected from copying is usually subsidized. "
Pharma, one of your examples, is both heavily protected and heavily subsidized. Heck, Intel gets huge R&D tax breaks too.
In truth, most of the heavily protected stuff is subsidized by tax payers in various forms anyway.
The idea that these companies are out there, doing it on their own, without essentially getting most of the R&D cost subsidized through tax breaks/etc, is a huge myth.
We don't have the model you propose. We have a model where it is both heavily protected and heavily subsidized.
Trade secrets, unlike patents and copyrights, are not a legal construct. They're just things you aren't telling anyone.
The bigger picture is that almost all hard R&D takes place under the umbrella of some sort of protection from copying. Intel spends billions a year on semiconductor R&D, and protects it with trade secrets. Pharma companies spend billions on drug R&D and protect them with patents. Even internet companies like Google and Facebook depend on being able to hide a lot of their "secret sauce" (either algorithms or compilations of user information) on the server-side where it can't be easily copied.
Hard R&D that isn't protected from copying is usually subsidized. The core internet protocols were subsidized by the Government. Advances in core browser protocols are subsidized by Internet companies that rely heavily on ad revenue. Going back further in history, Bell Labs was subsidized by AT&T's telephone monopoly and PARC was subsidized by Xerox's copier monopoly. That model can work too, but has its own problems.